A citation-based method for searching scientific literature

Krishnaraj S Rathod, Daniel A Jones, Ajay K Jain, Pitt Lim, Philip A MacCarthy, Roby Rakhit, Tim Lockie, Sundeep Kalra, Miles C Dalby, Iqbal S Malik, Mark Whitbread, Sam Firoozi, Richard Bogle, Simon Redwood, Jackie Cooper, Ajay Gupta, Alexandra Lansky, Andrew Wragg, Anthony Mathur, Amrita Ahluwalia. Am J Cardiovasc Dis 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


PCSK9 Activity Is Potentiated Through HDL Binding.
Sean A Burnap, Katherine Sattler, Raimund Pechlaner, Elisa Duregotti, Ruifang Lu, Konstantinos Theofilatos, Kaloyan Takov, Gerd Heusch, Sotirios Tsimikas, Carlos Fernández-Hernando,[...]. Circ Res 2021
3
100

Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9).
Yu Wang, Jiantao Ye, Jie Li, Cheng Chen, Junying Huang, Peiqing Liu, Heqing Huang. Cardiovasc Diabetol 2016
45
100

Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans.
T C Ooi, A Raymond, M Cousins, C Favreau, M Taljaard, C Gavin, E E Jolly, S Malone, L Eapen, M Chretien,[...]. Clin Chim Acta 2015
18
100

Gender difference of symptoms of acute coronary syndrome among Chinese patients: a cross-sectional study.
Libin An, Wentao Li, Hongling Shi, Xiaohua Zhou, Xin Liu, Huina Wang, Ju Liu, Shuqin Fan. Eur J Cardiovasc Nurs 2019
4
100

Liver fat accumulation is associated with circulating PCSK9.
Massimiliano Ruscica, Nicola Ferri, Chiara Macchi, Marica Meroni, Claudia Lanti, Chiara Ricci, Marco Maggioni, Anna Ludovica Fracanzani, Sara Badiali, Silvia Fargion,[...]. Ann Med 2016
84
100


Sex-specific differences in survival after out-of-hospital cardiac arrest: a nationwide, population-based observational study.
Yoshikazu Goto, Akira Funada, Tetsuo Maeda, Hirofumi Okada, Yumiko Goto. Crit Care 2019
18
100

Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta.
Zufeng Ding, Shijie Liu, Xianwei Wang, Xiaoyan Deng, Yubo Fan, Changqing Sun, Yannian Wang, Jawahar L Mehta. Antioxid Redox Signal 2015
115
100

PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results?
Massimo R Mannarino, Amirhossein Sahebkar, Vanessa Bianconi, Maria-Corina Serban, Maciej Banach, Matteo Pirro. J Clin Lipidol 2018
28
100


Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines.
Shijie Liu, Xiaoyan Deng, Peng Zhang, Xianwei Wang, Yubo Fan, Sichang Zhou, Shengyu Mu, Jawahar L Mehta, Zufeng Ding. Cardiovasc Res 2020
23
100

Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study.
Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu,[...]. Cardiovasc Diabetol 2020
11
100

Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China.
Shijun Xia, Xin Du, Lizhu Guo, Jing Du, Clare Arnott, Carolyn S P Lam, Mark D Huffman, Hisatomi Arima, Yiqiang Yuan, Yang Zheng,[...]. Circulation 2020
28
100

Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease.
Sha Li, Yuan-Lin Guo, Rui-Xia Xu, Yan Zhang, Cheng-Gang Zhu, Jing Sun, Ping Qing, Na-Qiong Wu, Li-Xin Jiang, Jian-Jun Li. Atherosclerosis 2014
80
100

Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
Valentin Schlegel, Theresa Treuner-Kaueroff, Daniel Seehofer, Thomas Berg, Susen Becker, Uta Ceglarek, Joachim Thiery, Thorsten Kaiser. PLoS One 2017
9
100

Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study.
Thibaut Duparc, Jean-Bernard Ruidavets, Annelise Genoux, Cécile Ingueneau, Souad Najib, Jean Ferrières, Bertrand Perret, Laurent O Martinez. Sci Rep 2020
18
100

Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials.
Xin-Lin Zhang, Qing-Qing Zhu, Li Zhu, Jian-Zhou Chen, Qin-Hua Chen, Guan-Nan Li, Jun Xie, Li-Na Kang, Biao Xu. BMC Med 2015
163
100

Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease.
Asad Shabbir, Krishnaraj Sinhji Rathod, Rayomand Syrus Khambata, Amrita Ahluwalia. Annu Rev Pharmacol Toxicol 2021
9
100

Proprotein convertase subtilisin/Kexin type-9 (PCSK-9) inhibitors induced liver injury - a retrospective analysis.
Yousuf Zafar, Yasar Sattar, Waqas Ullah, Sohaib Roomi, Mamoon-Ur- Rashid, Muhammad Shayan Khan, Laura Schmidt. J Community Hosp Intern Med Perspect 2020
4
100

Gender differences in glucose homeostasis and diabetes.
Franck Mauvais-Jarvis. Physiol Behav 2018
119
100

Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.
Moumita Ghosh, Cecilia Gälman, Mats Rudling, Bo Angelin. J Lipid Res 2015
56
100

Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease.
Tara L Sedlak, May Lee, Mona Izadnegahdar, C Noel Bairey Merz, Min Gao, Karin H Humphries. Am Heart J 2013
93
100

Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry.
Ersilia M DeFilippis, Bradley L Collins, Avinainder Singh, David W Biery, Amber Fatima, Arman Qamar, Adam N Berman, Ankur Gupta, Mary Cawley, Malissa J Wood,[...]. Eur Heart J 2020
47
100

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Jennifer G Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S Stroes, Gisle Langslet, Frederick J Raal, Mahfouz El Shahawy,[...]. N Engl J Med 2015
100

PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction.
Meidi Utami Puteri, Nuriza Ulul Azmi, Mitsuyasu Kato, Fadlina Chany Saputri. Life (Basel) 2022
7
100


Acute coronary syndromes in women and men.
Neha J Pagidipati, Eric D Peterson. Nat Rev Cardiol 2016
64
100

Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 Ameliorates Liver Fibrosis via Mitigation of Intestinal Endotoxemia.
Yanting Zou, Shuyu Li, Beili Xu, Hongying Guo, Shuncai Zhang, Yu Cai. Inflammation 2020
5
100

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
Peter R Sinnaeve, Gregory G Schwartz, Daniel M Wojdyla, Marco Alings, Deepak L Bhatt, Vera A Bittner, Chern-En Chiang, Roger M Correa Flores, Rafael Diaz, Maria Dorobantu,[...]. Eur Heart J 2020
34
100

Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE study.
Nicola Ferri, Massimiliano Ruscica, Daniela Coggi, Alice Bonomi, Mauro Amato, Beatrice Frigerio, Daniela Sansaro, Alessio Ravani, Fabrizio Veglia, Nicolò Capra,[...]. Atherosclerosis 2020
16
100

Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Ik Jun Choi, Sungmin Lim, Dongjae Lee, Won Jik Lee, Kwan Yong Lee, Mi-Jeong Kim, Doo Soo Jeon. Am J Cardiol 2020
3
100

G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies.
Yasin Hussain, Qingming Ding, Philip W Connelly, J Howard Brunt, Matthew R Ban, Adam D McIntyre, Murray W Huff, Robert Gros, Robert A Hegele, Ross D Feldman. Arterioscler Thromb Vasc Biol 2015
33
100


Low PCSK-9 levels Are Associated with Favorable Neurologic Function after Resuscitation from out of Hospital Cardiac Arrest.
Anne Merrelaar, Nina Buchtele, Christoph Schriefl, Christian Clodi, Michael Poppe, Florian Ettl, Harald Herkner, Bernd Jilma, Michael Schwameis, Christian Schoergenhofer. J Clin Med 2020
2
100

LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial.
Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, Robert Giugliano, Terje R Pedersen, KyungAh Im, Huei Wang, Beat Knusel, Marc S Sabatine, Michelle L O'Donoghue. Eur J Prev Cardiol 2020
20
100

Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction.
Calvin L Colvin, Bharat Poudel, Adam P Bress, Catherine G Derington, Jordan B King, Ying Wen, Ligong Chen, Vera Bittner, Todd M Brown, Keri L Monda,[...]. J Clin Lipidol 2021
2
100

Leptin, Resistin, and Proprotein Convertase Subtilisin/Kexin Type 9: The Role of STAT3.
Chiara Macchi, Maria Francesca Greco, Margherita Botta, Paola Sperandeo, Paola Dongiovanni, Luca Valenti, Arrigo F G Cicero, Claudio Borghi, Maria Giovanna Lupo, Stefano Romeo,[...]. Am J Pathol 2020
19
100

Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome.
Kwi Hyun Bae, Sung Woo Kim, Yeon Kyung Choi, Jung Beom Seo, Namkyun Kim, Chang Yeon Kim, Won Kee Lee, Sungwoo Lee, Jung Guk Kim, In Kyu Lee,[...]. Diabetes Metab J 2018
19
100

Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.
Jie Shi, Weiwei Zhang, Yixin Niu, Ning Lin, Xiaoyong Li, Hongmei Zhang, Renming Hu, Guang Ning, Jiangao Fan, Li Qin,[...]. Cardiovasc Diabetol 2020
7
100

Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials.
Ioanna Kosmidou, Björn Redfors, Harry P Selker, Holger Thiele, Manesh R Patel, James E Udelson, E Magnus Ohman, Ingo Eitel, Christopher B Granger, Akiko Maehara,[...]. Eur Heart J 2017
36
100

Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.
Vera Bittner, Luqin Deng, Robert S Rosenson, Ben Taylor, Stephen P Glasser, Shia T Kent, Michael E Farkouh, Paul Muntner. J Am Coll Cardiol 2015
22
100

PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD.
Stefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta, Fabio Marra, Rosellina Margherita Mancina, Jussi Pihlajamäki, Dorota Kakol-Palm, Anne-Christine Andréasson, Paola Dongiovanni, Anna Ludovica Fracanzani,[...]. Liver Int 2021
14
100


Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.
C Noel Bairey Merz, Leslee J Shaw, Steven E Reis, Vera Bittner, Sheryl F Kelsey, Marian Olson, B Delia Johnson, Carl J Pepine, Sunil Mankad, Barry L Sharaf,[...]. J Am Coll Cardiol 2006
525
100

High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients.
Michele F Eisenga, Dorien M Zelle, John H Sloan, Carlo A J M Gaillard, Stephan J L Bakker, Robin P F Dullaart. Diabetes Care 2017
24
100

Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction.
Zhong Zhang, Teng-Fei Wei, Bei Zhao, Zhao Yin, Quan-Xing Shi, Pei-Lin Liu, Li-Feng Liu, Li Liu, Jing-Tao Zhao, Shuai Mao,[...]. Sci Rep 2019
14
100

Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment.
Christian Werner, Michael M Hoffmann, Karl Winkler, Michael Böhm, Ulrich Laufs. Vascul Pharmacol 2014
81
100

Effect of long-term physical activity on PCSK9, high- and low-density lipoprotein cholesterol, and lipoprotein(a) levels: a prospective observational trial
Michael Sponder, Ioana-Alexandra Campean, Daniel Dalos, Michael Emich, Monika Fritzer-Szekeres, Brigitte Litschauer, Jutta Bergler-Klein, Senta Graf, Jeanette Strametz-Juranek. Pol Arch Intern Med 2017
15
100

Sex differences in cardiometabolic disorders.
Eva Gerdts, Vera Regitz-Zagrosek. Nat Med 2019
135
100

Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders.
A M Yildirim, A O Koca, E Beyan, O Dogan, S Karakaya, Z Aksoz, D T Ertuğrul. Eur Rev Med Pharmacol Sci 2021
4
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.